EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
5.3.99.3 | 2-[3-(aminooxy)-2,2-dimethyl-3-oxopropyl]-3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(1-methylethyl)-1H-indole | IC50: 0.01 mM | Homo sapiens | |
5.3.99.3 | 3-[(5E)-3-(4-butylbenzyl)-1-(4-chlorobenzyl)-4-methylidene-5-[(2E)-4-methylpent-2-en-1-ylidene]-4,5-dihydro-1H-pyrrol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.00029 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-3-(3,3-dimethylbutanoyl)-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.00025 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.0032 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-3-methyl-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.0011 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-3-methyl-5-phenyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.00060 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-3-methyl-7-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.0043 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(1-methylethyl)-3-phenoxy-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.00065 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(1-methylethyl)-3-phenyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.0064 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(1-methylethyl)-3-[(2-methylphenyl)carbonyl]-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.00090 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(2'-chloro-2-fluorobiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000004 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(2,2'-difluorobiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000008 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(2-chlorobiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000022 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(2-fluoro-2'-methoxybiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000005 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(2-fluoro-2'-methylbiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000003 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(2-fluoro-3'-methylbiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000033 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(2-fluoro-4'-methylbiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000031 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(2-fluorobiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000007 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-(3-fluoro-4-pyridin-3-ylphenyl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000012 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-fluoro-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.0026 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-[2-fluoro-2'-(phenylcarbonyl)biphenyl-4-yl]-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000006 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(4-chlorobenzyl)-5-[3-fluoro-4-(pyrimidin-5-ylmethyl)phenyl]-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000032 mM | Homo sapiens | |
5.3.99.3 | 3-[1-(p-chlorobenzvl)-5-isopropyl-3-tert-butylthioindol-2-yl]-2,2-dimethylpropanoic acid | i.e. 3-[1-(p-chlorobenzvl)-5-isopropyl-3-tert-butylthioindol-2-yl]-2,2-dimethylpropanoic acid or FLAP, formerly designated L-663,536, a lipoxygenase inhibitor, IC50: 0.0016 mM | Homo sapiens | |
5.3.99.3 | 3-[3-(tert-butylsulfanyl)-1-methyl-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.01 mM | Homo sapiens | |
5.3.99.3 | 3-[3-(tert-butylsulfanyl)-5-(1-methylethyl)-1-(3-phenylpropyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.0032 mM | Homo sapiens | |
5.3.99.3 | 3-[3-(tert-butylsulfanyl)-5-(1-methylethyl)-1-prop-2-en-1-yl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.0067 mM | Homo sapiens | |
5.3.99.3 | 3-[3-(tert-butylsulfanyl)-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.01 mM | Homo sapiens | |
5.3.99.3 | 3-[3-[(tert-butylsulfanyl)acetyl]-1-(4-chlorobenzyl)-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.00026 mM | Homo sapiens | |
5.3.99.3 | 3-[5-biphenyl-3-yl-1-(4-chlorobenzyl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.00016 mM | Homo sapiens | |
5.3.99.3 | 3-[5-biphenyl-4-yl-1-(4-chlorobenzyl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.000016 mM | Homo sapiens | |
5.3.99.3 | 3-[5-tert-butyl-1-(4-chlorobenzyl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | IC50: 0.00033 mM | Homo sapiens | |
5.3.99.3 | deoxy-prostaglandin J2 | IC50: 0.0003 mM | Homo sapiens | |
5.3.99.3 | methyl 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoate | IC50: 0.0072 mM | Homo sapiens | |
5.3.99.3 | additional information | structure-activity relationship analysis of inhibitors | Homo sapiens | |
5.3.99.3 | NS-398 | COX-2 inhibitor, IC50: 0.01-0.02 mM | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
5.3.99.3 | microsome | - |
Homo sapiens | - |
- |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.3.99.3 | Prostaglandin H2 | Homo sapiens | - |
Prostaglandin E2 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
5.3.99.3 | Homo sapiens | - |
inducible isozyme mPGES-1 | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
5.3.99.3 | A-549 cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.3.99.3 | Prostaglandin H2 | - |
Homo sapiens | Prostaglandin E2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
5.3.99.3 | mPGES-1 | - |
Homo sapiens |
5.3.99.3 | prostaglandin E2 synthase | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
5.3.99.3 | 0.000003 | - |
IC50: 0.000003 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(2-fluoro-2'-methylbiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000004 | - |
IC50: 0.000004 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(2'-chloro-2-fluorobiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000005 | - |
IC50: 0.000005 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(2-fluoro-2'-methoxybiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000006 | - |
IC50: 0.000006 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-[2-fluoro-2'-(phenylcarbonyl)biphenyl-4-yl]-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000007 | - |
IC50: 0.000007 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(2-fluorobiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000008 | - |
IC50: 0.000008 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(2,2'-difluorobiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000012 | - |
IC50: 0.000012 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(3-fluoro-4-pyridin-3-ylphenyl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000016 | - |
IC50: 0.000016 mM | Homo sapiens | 3-[5-biphenyl-4-yl-1-(4-chlorobenzyl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000022 | - |
IC50: 0.000022 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(2-chlorobiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000031 | - |
IC50: 0.000031 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(2-fluoro-4'-methylbiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000032 | - |
IC50: 0.000032 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-[3-fluoro-4-(pyrimidin-5-ylmethyl)phenyl]-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.000033 | - |
IC50: 0.000033 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(2-fluoro-3'-methylbiphenyl-4-yl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.00016 | - |
IC50: 0.00016 mM | Homo sapiens | 3-[5-biphenyl-3-yl-1-(4-chlorobenzyl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.00025 | - |
IC50: 0.00025 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-3-(3,3-dimethylbutanoyl)-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.00026 | - |
IC50: 0.00026 mM | Homo sapiens | 3-[3-[(tert-butylsulfanyl)acetyl]-1-(4-chlorobenzyl)-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.00029 | - |
IC50: 0.00029 mM | Homo sapiens | 3-[(5E)-3-(4-butylbenzyl)-1-(4-chlorobenzyl)-4-methylidene-5-[(2E)-4-methylpent-2-en-1-ylidene]-4,5-dihydro-1H-pyrrol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0003 | - |
IC50: 0.0003 mM | Homo sapiens | deoxy-prostaglandin J2 | |
5.3.99.3 | 0.00033 | - |
IC50: 0.00033 mM | Homo sapiens | 3-[5-tert-butyl-1-(4-chlorobenzyl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0006 | - |
IC50: 0.00060 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-3-methyl-5-phenyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.00065 | - |
IC50: 0.00065 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(1-methylethyl)-3-phenoxy-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0009 | - |
IC50: 0.00090 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(1-methylethyl)-3-[(2-methylphenyl)carbonyl]-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0011 | - |
IC50: 0.0011 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-3-methyl-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0016 | - |
i.e. 3-[1-(p-chlorobenzvl)-5-isopropyl-3-tert-butylthioindol-2-yl]-2,2-dimethylpropanoic acid or FLAP, formerly designated L-663,536, a lipoxygenase inhibitor, IC50: 0.0016 mM | Homo sapiens | 3-[1-(p-chlorobenzvl)-5-isopropyl-3-tert-butylthioindol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0026 | - |
IC50: 0.0026 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-fluoro-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0032 | - |
IC50: 0.0032 mM | Homo sapiens | 3-[3-(tert-butylsulfanyl)-5-(1-methylethyl)-1-(3-phenylpropyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0032 | - |
IC50: 0.0032 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-3-methyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0043 | - |
IC50: 0.0043 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-3-methyl-7-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0064 | - |
IC50: 0.0064 mM | Homo sapiens | 3-[1-(4-chlorobenzyl)-5-(1-methylethyl)-3-phenyl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0067 | - |
IC50: 0.0067 mM | Homo sapiens | 3-[3-(tert-butylsulfanyl)-5-(1-methylethyl)-1-prop-2-en-1-yl-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.0072 | - |
IC50: 0.0072 mM | Homo sapiens | methyl 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoate | |
5.3.99.3 | 0.01 | - |
IC50: 0.01 mM | Homo sapiens | 3-[3-(tert-butylsulfanyl)-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.01 | - |
IC50: 0.01 mM | Homo sapiens | 3-[3-(tert-butylsulfanyl)-1-methyl-5-(1-methylethyl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid | |
5.3.99.3 | 0.01 | - |
IC50: 0.01 mM | Homo sapiens | 2-[3-(aminooxy)-2,2-dimethyl-3-oxopropyl]-3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(1-methylethyl)-1H-indole | |
5.3.99.3 | 0.01 | 0.02 | COX-2 inhibitor, IC50: 0.01-0.02 mM | Homo sapiens | NS-398 |